PCYC

Pharmacyclics, Inc. News Headlines

$108.5
*  
3.68
3.51%
Get PCYC Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
7/28/2014 5:15:00 PM - Zacks.com

Press Release: FDA expands approved use of Imbruvica for chronic lymphocytic leukemia
7/28/2014 12:38:00 PM - Dow Jones Business News

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

Stocks Under Pressure In Reaction To Yellen's Testimony - U.S. Commentary
7/15/2014 12:20:00 PM - RTT News

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha

Individual Investor Portfolio Update: Diversifying For Growth
7/1/2014 1:40:00 AM - Seeking Alpha

Cramer's Mad Money - 9 Things To Watch In The Week Ahead (6/20/14)
6/22/2014 5:10:00 AM - Seeking Alpha

Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha

Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog
6/10/2014 6:45:00 PM - Zacks.com

Stocks Extending Upward Move, Dow And S&P 500 Set New Highs - U.S. Commentary
6/9/2014 12:04:00 PM - RTT News

An Ode To Pharmacyclics...
6/3/2014 8:50:00 AM - RTT News

Encouraging Data on Pharmacyclics/J&J Drug - Analyst Blog
6/2/2014 12:10:00 PM - Zacks.com

Stocks May Open Higher On Upbeat Chinese Manufacturing Data - U.S. Commentary
6/2/2014 8:57:00 AM - RTT News

Mid-Afternoon Market Update: Nimble Storage Rallies As Pharmacyclics Shows Weakness
5/23/2014 3:49:32 PM - Benzinga

PCYC July 3rd Options Begin Trading
5/22/2014 11:10:12 AM - BNK Invest

Cramer's Lightning Round - I'm Taking A Stand For Pharmacyclics (5/5/14)
5/6/2014 6:55:00 AM - Seeking Alpha

Monday's ETF Movers: FBT, XME
5/5/2014 4:12:48 PM - BNK Invest

Zacks' Bull Of The Day: Gilead Sciences
5/5/2014 2:20:00 PM - Seeking Alpha

Earnings Beat at Pharmacyclics, Guidance Pulls Down Stock - Analyst Blog
5/5/2014 11:30:01 AM - Zacks.com

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
5/5/2014 2:49:01 AM - Zacks.com

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
5/5/2014 1:49:00 AM - Investopedia

Stocks Turning In Yet Another Lackluster Performance - U.S. Commentary
5/2/2014 12:00:00 PM - RTT News

Earnings Reaction History: Pharmacyclics Inc., 66.7% Follow-Through Indicator, 4.3% Sensitive
5/2/2014 6:31:53 AM - MT Newswires

Pre-Market Earnings Report for May 2, 2014 : CVX, CVS, TRP, MMC, SRE, EL, SWN, BPL, NWL, PCYC, GIL, PNW
5/1/2014 4:00:03 PM - NASDAQ.com News